Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03858517
Other study ID # ReUnion TSA Study
Secondary ID
Status Terminated
Phase
First received
Last updated
Start date June 25, 2019
Est. completion date July 8, 2022

Study information

Verified date July 2022
Source Stryker Trauma GmbH
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This investigation is a prospective, multicenter clinical investigation. It is anticipated that a total of one hundred (100) subjects will be enrolled at approximately 4-7 sites. The clinical investigation has been designed to follow the surgeon's standard of care for joint arthroplasty subjects, which entails clinical evaluation on a regular ongoing basis, or as needed should the subject become symptomatic in the treated joint.


Description:

The objective of this clinical investigation is to demonstrate the safety and efficacy/performance of the ReUnion TSA System. Efficacy/performance of the procedure will be measured the American Shoulder and Elbow Surgeons (ASES) Shoulder Score. Safety of the ReUnion TSA System will be demonstrated through reporting of device-related intra-operative and post-operative Adverse Events (AEs). Enrolled subjects will be assessed at Pre-Operative, Operative/Discharge, and at 6 Weeks, 6 Months, 12 Months, 24 Months and annually thereafter up to 10 years following the index procedure.


Recruitment information / eligibility

Status Terminated
Enrollment 56
Est. completion date July 8, 2022
Est. primary completion date July 8, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - Subject is willing to sign the informed consent. - Subject is willing and able to comply with postoperative scheduled clinical and radiographic evaluations. - Subject is male or non-pregnant female and 18 years or older at the time of surgery. - Subject has one or more of the following: - Aseptic necrosis of the humeral head - Painful, disabling joint disease of the shoulder resulting from degenerative arthritis, rheumatoid arthritis or post-traumatic arthritis - Failed previous total shoulder replacement, resurfacing or other procedure Exclusion Criteria: - Subject has an active or suspected latent infection in or about the shoulder joint. - Subject has mental or neuromuscular disorder which would create an unacceptable risk of prosthesis instability, prosthesis fixation failure or complications in postoperative care. - Subject has bone stock compromised by disease, infection or prior implantation which cannot provide adequate support and/or fixation to the prosthesis. - Subject has anticipated activities which would impose high stresses on the prosthesis and its fixation. - Subject is obese such that he/she produces a load on the prosthesis which can lead to failure of fixation of the device or to failure of the device itself. - Subject has absent, irreparable or non-functioning rotator cuff and other essential muscles. - Subject has concomitant disease(s) which may significantly affect the clinical outcome. - Subject has traumatic or pathologic fracture of the proximal humerus.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
ReUnion TSA System
The ReUnion TSA System is designed as an anatomical total shoulder or hemi-shoulder endoprosthesis to address advanced arthritic disorders affecting the shoulder joint in subjects having intact or repairable rotator cuff function. The ReUnion TSA System consists of a completely modular shoulder platform including a Humeral Stem, Humeral Head and Glenoid. The intended purposes of the ReUnion TSA System are to achieve pain relief, improvement of range of motion and restoration or improvement of the shoulder function while ensuring long-term replacement of the shoulder joint with sufficient stability of all endoprosthesis components.

Locations

Country Name City State
United States Steadman Hawkins Clinic of the Carolinas Greenville South Carolina
United States Tennessee Orthopaedic Alliance Nashville Michigan
United States Great Plains Orthopedics Peoria Illinois

Sponsors (1)

Lead Sponsor Collaborator
Stryker Trauma GmbH

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary American Shoulder and Elbow Surgeons (ASES) Shoulder Score The primary endpoint of the clinical investigation is to demonstrate non-inferiority of the device to the selected literature controls, as measured by the ASES Shoulder Score at 24 Months post-operative. 24 months
Secondary Safety will be measured by capturing the incidence rate of device-related intra-operative and post-operative adverse events will be measured. Secondary outcome measures to assess safety by capturing the incidence rate of device-related intra-operative adverse events. 10 years
Secondary Efficacy will be measured by monitoring all implant survivorship in all subjects who have the total or partial prosthesis with full or partial implant survival. Secondary outcome measures to assess efficacy by monitoring all implant survivorship in all subjects enrolled who have the ReUnion RFX System. 10 years
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05965986 - Preoperative Rehabilitation and Education Program N/A
Completed NCT05020821 - Superior Trunk Block Catheter Versus Single-shot Superior Trunk Block With Intravenous Dexmedetomidine for Shoulder Arthroplasty N/A
Completed NCT05350319 - Prospective Low Dose CT for Total Shoulder Arthroplasty/Reverse Shoulder Arthroplasty
Terminated NCT03845894 - Interscalene Block With Liposomal Bupivacaine vs. Interscalene Block With Bupivacaine and Adjuvants Phase 4
Recruiting NCT05699031 - Shoulder Prosthesis Telerehab Care Trial N/A
Completed NCT04822610 - Comparison of Interscalene Block and Suprascapular With Axillary Block N/A
Terminated NCT03880955 - A Post-Market Clinical Evaluation of the ReUnion Reverse Shoulder Arthroplasty (RSA) System
Recruiting NCT03511586 - Total Shoulder Arthroplasty Multi-Center Registry
Completed NCT04112407 - The Effect of Pretreatment for Propionibacterium Acnes on Surgical Site Burden in Shoulder Arthroplasty N/A
Recruiting NCT03268837 - Programmed Intermittent Bolus During Continuous Interscalene Nerve Block for Shoulder Arthroplasty N/A
Active, not recruiting NCT06281574 - What Are the Determinants for RTW After SA
Completed NCT05179941 - Subscapularis Indocyanine Green Perfusion Pilot Study N/A
Completed NCT03578237 - Cryoanalgesia to Prevent Acute and Chronic Pain Following Surgery: A Randomized, Double-Masked, Sham-Controlled Study N/A
Recruiting NCT00527839 - Hospital for Special Surgery Shoulder Arthroplasty Cohort